ロード中...
Role of Gliclazide MR in the Management of Type 2 Diabetes: Report of a Symposium on Real-World Evidence and New Perspectives
In patients with type 2 diabetes mellitus (T2DM) who require additional glucose-lowering on top of first-line metformin monotherapy, sulfonylureas are the most common choice for second-line therapy followed by dipeptidyl peptidase inhibitors (DPP-4i). This article summarises presentations at a sympo...
保存先:
| 出版年: | Diabetes Ther |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7415040/ https://ncbi.nlm.nih.gov/pubmed/32440835 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-020-00833-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|